Department of Medicine, Harvard Medical School, Boston, MA, USA.
Department of Orthopedics, Chinese PLA General Hospital, Beijing, China.
Osteoporos Int. 2019 Apr;30(4):923-927. doi: 10.1007/s00198-019-04847-5. Epub 2019 Jan 24.
Intervals between dual-energy X-ray absorptiometry (DXA) scans were evaluated in a large cohort of typical clinical practice. Intensive DXA scanning (intervals < 23 months) decreased substantially, from 16.7% in 2006 to 6.7% in 2015.
Serial dual-energy X-ray absorptiometry (DXA) measurements are suggested for patients at high risk of fractures. However, little is known about how often DXA testing occurs in clinical practice.
We examined time intervals between DXA testing for monitoring purpose at two academic medical centers in the US between 2004 and 2017. The primary outcome was the presence of testing intervals < 23 months (termed "intensive DXA testing"). A generalized linear mixed model was used to evaluate the association between selected patient-level clinical factors and intensive DXA testing.
Forty-nine thousand four hundred ninety-four DXA tests from 20,200 patients were analyzed. The mean time interval between scans was 36 ± 21 months. Only 11.1% of the repeated DXA testing met the criterion for intensive testing. The percentage of intensive DXA testing dropped from 16.7% in 2006 to 6.7% in 2015 (p for trend < 0.001). After adjusting for age, gender, number of outpatient visits, and calendar year, correlates of intensive DXA testing included a baseline T-score < -2.5 at any anatomic site (OR, 4.8; 95%CI, 4.0-5.7), active use of drugs for osteoporosis (OR, 1.6; 95%CI, 1.3-1.9), and active use of glucocorticoids (OR, 1.3; 95%CI, 1.2-1.4).
The predictors of intensive DXA testing suggest that this practice is used preferentially in patients with multiple risk factors and to monitor the response to pharmacotherapy. However, intensive DXA testing has become less common in real-world clinical practice over the last decade. Further studies are required to better define the optimal use of bone mineral density testing in this vulnerable population.
在一项大型典型临床实践队列中评估了双能 X 射线吸收法 (DXA) 扫描之间的时间间隔。密集的 DXA 扫描(间隔 < 23 个月)大幅减少,从 2006 年的 16.7%降至 2015 年的 6.7%。
建议对骨折高风险患者进行连续双能 X 射线吸收法 (DXA) 测量。然而,对于临床实践中 DXA 检测的频率知之甚少。
我们在美国的两家学术医疗中心检查了 2004 年至 2017 年期间用于监测目的的 DXA 检测时间间隔。主要结果是存在间隔 < 23 个月的检测(称为“密集 DXA 检测”)。使用广义线性混合模型评估选定的患者水平临床因素与密集 DXA 检测之间的关联。
分析了来自 20200 名患者的 49494 次 DXA 测试。扫描之间的平均时间间隔为 36 ± 21 个月。只有 11.1%的重复 DXA 测试符合密集测试标准。密集 DXA 测试的百分比从 2006 年的 16.7%降至 2015 年的 6.7%(趋势 p < 0.001)。在校正年龄、性别、门诊就诊次数和日历年后,密集 DXA 检测的相关因素包括任何解剖部位的基线 T 评分 < -2.5(比值比,4.8;95%置信区间,4.0-5.7)、骨质疏松症药物的积极使用(比值比,1.6;95%置信区间,1.3-1.9)和糖皮质激素的积极使用(比值比,1.3;95%置信区间,1.2-1.4)。
密集 DXA 检测的预测因素表明,这种做法主要用于具有多种危险因素的患者,并用于监测药物治疗反应。然而,在过去十年中,实际临床实践中密集 DXA 检测的频率已降低。需要进一步的研究来更好地定义在这一脆弱人群中骨密度检测的最佳使用。